Wu Chunyang, Zhou Ying, Ai Wenxiu, Guo Yinjuan, Wu Xiaocui, Wang Bingjie, Zhao Huilin, Rao Lulin, Wang Xinyi, Zhang Jiao, Yu Fangyou, Wang Liangxing
Department of Respiratory Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Department of Clinical Laboratory Medicine, Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China.
Front Microbiol. 2023 Feb 28;14:1133590. doi: 10.3389/fmicb.2023.1133590. eCollection 2023.
The emergence of carbapenem-resistant (CRKP) strains and restricted therapeutic options pose a global threat to public health. Aminoglycosides are a wise choice, which can effectively reduce the mortality rate when combined with β-lactam drugs. However, in this study, we identified a ST15-KL112 CRKP FK3006 which not only exhibited resistance to carbapenems, but also exhibited high level resistance to aminoglycosides. In addition to the multidrug resistant phenotype, FK3006 also owned typical pathogenic characteristic, including hypermucoviscosity and hypervirulence phenotypes. According to the whole-genome sequencing, one pLVPK-like virulence plasmid, and three key resistant plasmids ( , , and ) were observed in FK3006. Compared to other typical ST15 CRKP, the presence of pLVPK-like virulence plasmid (p3006-2) endowed the FK3006 with high virulence features. High siderophore production, more cell invasive and more resistant to serum killing was observed in FK3006. The infection model also further confirmed the hypervirulent phenotype of FK3006 Moreover, according to the conjugation assay, p3006-2 virulence plasmid also could be induced transfer with the help of conjugative IncFII p3006-11 plasmid ( ). In addition to the transmissible plasmid, several insertion sequences and transposons were found around , and to generate the mobile antimicrobial resistance island (ARI), which also make a significant contribution to the dissemination of resistant determinants. Overall, we reported the uncommon co-existence of , -encoding plasmids, and pLVPK-like virulence plasmid in ST15-KL112 . The dissemination threatens of these high-risk elements in indicated that future studies are necessary to evaluate the prevalence of such isolates.
耐碳青霉烯类肺炎克雷伯菌(CRKP)菌株的出现以及有限的治疗选择对全球公共卫生构成了威胁。氨基糖苷类药物是一个明智的选择,与β-内酰胺类药物联合使用时可有效降低死亡率。然而,在本研究中,我们鉴定出一株ST15-KL112 CRKP FK3006,它不仅对碳青霉烯类药物耐药,还对氨基糖苷类药物表现出高水平耐药。除了多重耐药表型外,FK3006还具有典型的致病特征,包括高黏液性和高毒力表型。根据全基因组测序,在FK3006中观察到一个pLVPK样毒力质粒和三个关键耐药质粒( 、 和 )。与其他典型的ST15 CRKP相比,pLVPK样毒力质粒(p3006-2)的存在赋予了FK3006高毒力特征。在FK3006中观察到高铁载体产量、更强的细胞侵袭性和对血清杀伤的更高抵抗力。 感染模型也进一步证实了FK3006的高毒力表型。此外,根据接合试验,p3006-2毒力质粒在接合性IncFII p3006-11质粒( )的帮助下也可被诱导转移。除了可传播的质粒外,在 、 和 周围还发现了几个插入序列和转座子,以产生移动性抗菌耐药岛(ARI),这也对抗药决定簇的传播做出了重大贡献。总体而言,我们报道了ST15-KL112中 、 编码质粒和pLVPK样毒力质粒罕见的共存情况。这些高风险元件在 中的传播威胁表明,未来有必要开展研究以评估此类分离株的流行情况。